Outcome for Advanced or Metastatic Soft Tissue Sarcoma of Nonextremities Treated with Doxorubicin-Based Chemotherapy: A Retrospective Study from a Single Cancer Institution

Figure 3

Difference of (a) TTF and (b) OS in doses of doxorubicin monotherapy.

(a)

(b)